Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/15/2025

Guidelines for Managing Recurrent Epistaxis

Initial Assessment and Management

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends that clinicians distinguish patients requiring prompt management from those who do not, assessing for airway compromise and hemodynamic stability 1, 2
  • For active bleeding, applying firm sustained compression to the lower third of the nose for 5-15 minutes with the patient seated and head tilted slightly forward can be effective 3, 4
  • Patients should breathe through the mouth and spit out blood rather than swallowing it 3, 4
  • After compression, cleaning the nasal cavity of clots and applying a topical vasoconstrictor (oxymetazoline or phenylephrine) can stop bleeding in 65-75% of cases 3, 4

Identifying and Documenting Risk Factors

  • Clinicians should document factors that increase frequency or severity of bleeding for any patient with epistaxis, including use of anticoagulant or antiplatelet medications 2, 3, 5
  • Common risk factors include hypertension 6, nasal trauma or digital manipulation 1, dry nasal mucosa 4, and hereditary conditions like hereditary hemorrhagic telangiectasia (HHT) 7

Treatment Options for Recurrent Epistaxis

  • The American Academy of Otolaryngology-Head and Neck Surgery recommends applying moisturizing or lubricating agents (petroleum jelly) to the nasal mucosa to prevent recurrence 3, 4
  • Regular use of saline nasal sprays is recommended to keep the nasal mucosa moist 3, 4
  • Nasal cautery should be considered if a specific bleeding site is identified 2, 5
  • Tranexamic acid has shown efficacy in reducing epistaxis in hereditary hemorrhagic telangiectasia patients 7

Special Considerations

  • Assess for nasal telangiectasias and/or oral mucosal telangiectasias in patients with recurrent bilateral nosebleeds or family history of recurrent nosebleeds to rule out hereditary hemorrhagic telangiectasia 2, 7

Follow-up Recommendations

  • Document the outcome of intervention within 30 days 2, 3
  • Educate patients about preventive measures for nosebleeds, home treatment for nosebleeds, and indications to seek additional medical care 2, 3

Common Pitfalls to Avoid

  • Avoid bilateral simultaneous septal cautery as it may increase risk of septal perforation 6, 8
  • Don't underestimate the importance of simple measures like nasal moisturization, which can be highly effective in preventing recurrence 4

REFERENCES

1

clinical practice guideline: nosebleed (epistaxis). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

2

clinical practice guideline: nosebleed (epistaxis). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

3

Management of Recurrent Epistaxis in Patients on Anticoagulation Therapy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Epistaxis Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

clinical practice guideline: nosebleed (epistaxis). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

6

clinical practice guideline: nosebleed (epistaxis). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020

8

clinical practice guideline: nosebleed (epistaxis). [LINK]

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2020